共 124 条
[1]
Tobert JA(1987)New developments in lipid-lowering therapy: the role of inhibitors of hydroxymethylglutaryl-coenzyme A reductase Circulation 76 534-8
[2]
Freeman DJ(2001)Pravastatin and the development of diabetes mellitus: evidence for a protective treatment effect in the West of Scotland Coronary Prevention Study Circulation 103 357-62
[3]
Norrie J(2016)The diabetogenic action of statins—mechanisms and clinical implications Nat Rew Endocrinol 12 99-110
[4]
Sattar N(2012)Statin use and risk of diabetes mellitus in postmenopausal women in the Women’s Health Initiative Arch Intern Med 172 144-52
[5]
Betteridge DJ(2013)Statins and risk of treated incident diabetes in a primary care population Br J Clin Pharmacol 75 1118-24
[6]
Carmena R(2014)Statins and the risk of type 2 diabetes mellitus: cohort study using the UK clinical practice pesearch datalink BMC Cardiovasc Disord 14 85-17
[7]
Culver AL(2015)Increased risk of diabetes with statin treatment is associated with impaired insulin sensitivity and insulin secretion: a 6 year follow-up study of the METSIM cohort Diabetologia 58 1109-7
[8]
Ockene IS(2016)Impact of statin use on development of new-onset diabetes mellitus in Asian population Am J Cardiol 117 382-207
[9]
Balasubramanian R(2008)Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein N Engl J Med 359 2195-61
[10]
Zaharan NL(2007)Rosuvastatin in older patients with systolic heart failure N Engl J Med 357 2248-9